Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study
Justyna Pełka-Wysiecka, Mariusz Kaczmarczyk, Agata Bąba-Kubiś, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1605-1605
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review
Karolina Skonieczna‐Żydecka, Karolina Jakubczyk, Dominika Maciejewska, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3369-3369
Open Access | Times Cited: 31
The gut microbiome and antipsychotic treatment response
Mary V. Seeman
Behavioural Brain Research (2020) Vol. 396, pp. 112886-112886
Closed Access | Times Cited: 30
The schizophrenia and gut microbiota: A bibliometric and visual analysis
Chao Yang, Xiaoxiao Lin, Xianteng Wang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
Georgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 531-541
Open Access | Times Cited: 16
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
Hui Chen, Ting Cao, Bikui Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Comparative analysis of gut microbiota in major depressive disorder and schizophrenia during hospitalisation - the case-control, post hoc study.
Agata Misera, Mariusz Kaczmarczyk, Igor Łoniewski, et al.
Psychoneuroendocrinology (2024) Vol. 171, pp. 107208-107208
Open Access | Times Cited: 3
Inflammation in Mental Disorders: Is the Microbiota the Missing Link?
Sophie Ouabbou, Ying Hé, Keith Butler, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 9, pp. 1071-1084
Open Access | Times Cited: 26
Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study
Jinchi Zheng, Zeya Lin, Chih‐Yuan Ko, et al.
Behavioural Neurology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 15
Modulation of Gut Microbial Diversity through Non-Pharmaceutical Approaches to Treat Schizophrenia
Nayla Munawar, Aftab Ahmad, Munir Ahmad Anwar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2625-2625
Open Access | Times Cited: 14
The Microbiota/Microbiome and the Gut–Brain Axis: How Much Do They Matter in Psychiatry?
Donatella Marazziti, Beatrice Buccianelli, Stefania Palermo, et al.
Life (2021) Vol. 11, Iss. 8, pp. 760-760
Open Access | Times Cited: 18
The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study
Xinyu Fang, Chunying Gao, Weifeng Wu, et al.
Psychiatry Research (2023) Vol. 328, pp. 115463-115463
Closed Access | Times Cited: 6
Analysis of gut microbiota in patients with epilepsy treated with valproate: Results from a three months observational prospective cohort study
Xue Gong, Yue Liu, Xu Liu, et al.
Microbial Pathogenesis (2021) Vol. 162, pp. 105340-105340
Closed Access | Times Cited: 12
Disrupted diurnal oscillations of the gut microbiota in patients with alcohol dependence
Kangqing Zhao, Zhaojun Ni, Ying Qin, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Natural molecules in the treatment of schizophrenia
Nayla Munawar, Khansa Ahsan, Aftab Ahmad
Elsevier eBooks (2024), pp. 259-280
Closed Access | Times Cited: 1
Clinical Translation of Microbe-Based Therapies
Sangeetha Murthy, Ramasamy Balagurunathan, Sivarajan Anbalmani, et al.
(2024), pp. 167-181
Closed Access | Times Cited: 1
Early prediction of olanzapine-induced weight gain for schizophrenia patients
Ching‐Hua Lin, Shih‐Chi Lin, Yuhui Huang, et al.
Psychiatry Research (2018) Vol. 263, pp. 207-211
Closed Access | Times Cited: 10
Psycho-pharmacomicrobiomics: a systematic review and meta-analysis
Amedeo Minichino, Tabitha Person, Jack B. Fanshawe, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3
Disruptions within gut microbiota composition induced by improper antibiotics therapy as a probable trigger factor for development of depression – Case Reports
Małgorzata Janowska, Joanna Róg, Hanna Karakuła‐Juchnowicz
Annals of Agricultural and Environmental Medicine (2021) Vol. 28, Iss. 4, pp. 713-718
Open Access | Times Cited: 7
Dysbiosis, gut-blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia
Maria Maślińska, Beata Trędzbor, Marek Krzystanek
Reumatologia/Rheumatology (2021) Vol. 59, Iss. 3, pp. 180-187
Open Access | Times Cited: 6
Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic
Tahlia R. Meola, Srinivas Kamath, Aurelia S. Elz, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114453-114453
Open Access
Small Bowel—Key Player in Health and Disease
Wojciech Marlicz, Anastasios Koulaouzidis
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1748-1748
Open Access | Times Cited: 2
Description of the fecal microbiota of siblings from Costa Rica with and without affective and psychotic disorders
Sophie Ouabbou, Ching Jian, Alejandro Ávila-Aguirre, et al.
Journal of Affective Disorders Reports (2021) Vol. 4, pp. 100081-100081
Open Access | Times Cited: 1
Peer Review #1 of "Altered gut microbiota associated with symptom severity in schizophrenia (v0.1)"

(2020)
Open Access
Peer Review #1 of "Altered gut microbiota associated with symptom severity in schizophrenia (v0.2)"

(2020)
Open Access
Peer Review #2 of "Altered gut microbiota associated with symptom severity in schizophrenia (v0.2)"

(2020)
Open Access

Scroll to top